Sandrine Belouzard

Institutionuniversité de Lille
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 1 publications in June 2020 and October 2020 and January 2021 and February 2021 and June 2021 and August 2021
    All Publications
    Bar chart showing 43 publications over 17 distinct years, with a maximum of 5 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Eymieux S, Uzbekov R, Rouillé Y, Blanchard E, Hourioux C, Dubuisson J, Belouzard S, Roingeard P. Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress. Cells. 2021 08 10; 10(8). PMID: 34440816.
      Citations:    Fields:    Translation:AnimalsCells
    2. Ramirez S, Fernandez-Antunez C, Galli A, Underwood A, Pham LV, Ryberg LA, Feng S, Pedersen MS, Mikkelsen LS, Belouzard S, Dubuisson J, Sølund C, Weis N, Gottwein JM, Fahnøe U, Bukh J. Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication. Antimicrob Agents Chemother. 2021 06 17; 65(7):e0009721. PMID: 33903110.
      Citations: 7     Fields:    Translation:HumansAnimalsPHPublic Health
    3. Dechaumes A, Nekoua MP, Belouzard S, Sane F, Engelmann I, Dubuisson J, Alidjinou EK, Hober D. Fluoxetine Can Inhibit SARS-CoV-2 In Vitro. Microorganisms. 2021 Feb 09; 9(2). PMID: 33572117.
      Citations: 9     
    4. Eymieux S, Rouillé Y, Terrier O, Seron K, Blanchard E, Rosa-Calatrava M, Dubuisson J, Belouzard S, Roingeard P. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release. Cell Mol Life Sci. 2021 Apr; 78(7):3565-3576. PMID: 33449149.
      Citations: 3     Fields:    Translation:AnimalsCells
    5. Brochot E, Demey B, Touzé A, Belouzard S, Dubuisson J, Schmit JL, Duverlie G, Francois C, Castelain S, Helle F. Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals. Front Microbiol. 2020; 11:584251. PMID: 33193227.
      Citations: 39     
    6. Juckel D, Dubuisson J, Belouzard S. [Coronavirus, emerging viruses]. Med Sci (Paris). 2020 Jun-Jul; 36(6-7):633-641. PMID: 32558641.
      Citations:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Loczechin A, Séron K, Barras A, Giovanelli E, Belouzard S, Chen YT, Metzler-Nolte N, Boukherroub R, Dubuisson J, Szunerits S. Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus. ACS Appl Mater Interfaces. 2019 Nov 20; 11(46):42964-42974. PMID: 31633330.
      Citations: 62     Fields:    Translation:HumansCells
    8. Perrier A, Bonnin A, Desmarets L, Danneels A, Goffard A, Rouillé Y, Dubuisson J, Belouzard S. The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. J Biol Chem. 2019 09 27; 294(39):14406-14421. PMID: 31399512.
      Citations: 40     Fields:    Translation:HumansCells
    9. Ferlin J, Farhat R, Belouzard S, Cocquerel L, Bertin A, Hober D, Dubuisson J, Rouillé Y. Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses. J Gen Virol. 2018 08; 99(8):1086-1096. PMID: 29923822.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    10. Bonnin A, Danneels A, Dubuisson J, Goffard A, Belouzard S. HCoV-229E spike protein fusion activation by trypsin-like serine proteases is mediated by proteolytic processing in the S2' region. J Gen Virol. 2018 07; 99(7):908-912. PMID: 29786498.
      Citations: 6     Fields:    Translation:HumansCells
    11. Millet JK, Séron K, Labitt RN, Danneels A, Palmer KE, Whittaker GR, Dubuisson J, Belouzard S. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin. Antiviral Res. 2016 09; 133:1-8. PMID: 27424494.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    12. Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012 06; 4(6):1011-33. PMID: 22816037.
      Citations: 420     Fields:    Translation:HumansAnimalsCells
    13. Belouzard S, Madu I, Whittaker GR. Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain. J Biol Chem. 2010 Jul 23; 285(30):22758-63. PMID: 20507992.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    14. Madu IG, Belouzard S, Whittaker GR. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology. 2009 Oct 25; 393(2):265-71. PMID: 19717178.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    15. Madu IG, Roth SL, Belouzard S, Whittaker GR. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol. 2009 Aug; 83(15):7411-21. PMID: 19439480.
      Citations: 105     Fields:    Translation:HumansAnimalsCells
    16. Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A. 2009 Apr 07; 106(14):5871-6. PMID: 19321428.
      Citations: 412     Fields:    Translation:Cells